Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Diagnostic or test agent produces in vivo fluorescence
Patent
1997-07-30
2000-02-08
Huff, Sheela
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Diagnostic or test agent produces in vivo fluorescence
424 111, 424 165, 424 91, 424 93, 424 96, 435 71, 435 723, 436518, 436 64, 436 58, A61K 4900
Patent
active
060225262
ABSTRACT:
Melanotic melanoma tumor or cells, melanin, or melanin metabolites are detected, identified, and localized when bound to texaphyrins or texaphyrin metal complexes. The present invention provides texaphyrins and texaphyrin metal complexes as reagents for in vivo or in vitro detection for melanin or melanin metabolites predictive of the presence of melanotic melanoma.
REFERENCES:
patent: 4749559 (1988-06-01), Kebabian
patent: 4843020 (1989-06-01), Woodford
patent: 4935498 (1990-06-01), Sessler et al.
patent: 5021236 (1991-06-01), Gries et al.
patent: 5252720 (1993-10-01), Sessler et al.
patent: 5256399 (1993-10-01), Sessler
patent: 5292414 (1994-03-01), Sessler et al.
patent: 5310539 (1994-05-01), Williams
patent: 5457183 (1995-10-01), Sessler et al.
patent: 5559207 (1996-09-01), Sessler et al.
patent: 5565552 (1996-10-01), Magda et al.
patent: 5567687 (1996-10-01), Magda et al.
patent: 5576013 (1996-11-01), Williams et al.
patent: 5583220 (1996-12-01), Sessler et al.
patent: 5587371 (1996-12-01), Sessler et al.
patent: 5587463 (1996-12-01), Sessler et al.
patent: 5591422 (1997-01-01), Hemmi et al.
patent: 5594136 (1997-01-01), Sessler et al.
patent: 5595726 (1997-01-01), Magda et al.
patent: 5599923 (1997-02-01), Sessler et al.
patent: 5599928 (1997-02-01), Hemmi et al.
patent: 5601802 (1997-02-01), Hemmi et al.
patent: 5607924 (1997-03-01), Magda et al.
patent: 5622946 (1997-04-01), Sessler et al.
Anderson, et al., "The Optics of Human Skin," J. of Investigative Dermatology, 77(1):13-19, 1981.
Associated Regional and University Pathologists, Inc., "Melanin, Urine," Internet: http://www.arup-lab.com/ug/ugar1399.htm, updated Apr. 1, 1997.
Atlas, et al., "Human Malignant Melanomas with Varying Degrees of Melanin Content in Nude Mice: MR Imaging, Histopathology, and Electron Paramagnetic Resonance," Journal of Computer Assisted Tomography, 14(4):547-554,1990.
Ball, et al., "Surgical Management of Malignant Melanoma," British Medical Bulletin, 51(3):584-608, 1995.
Biolo, et al., "Photodynamic Therapy of B16 Pigmented Melanoma with Liposome-Delivered Si(IV)-Naphthalocyanine," Photochem. And Photobiol., 59(3):362-365, 1994.
Borovansky, J., "Properties of melanosomes and their exploitation in the diagnosis and treatment of melanoma," Melanoma Research, 3:181-186, 1993.
Brown, et al., "New Light on Cancer Therapy," Chemistry in Britain, pp. 955-958, 1993.
Cochran, et al., "Melanocytic Tumors: A Guide to Diagnosis," Evaluative Techniques for Melanocytic Tumors, 298-299, Sep., 1996.
Dougherty, T.J., "Photoradiation Therapy for Cutaneous and Subcutaneous Malignancies," The Journal of Investigative Dermatology, 77:122-124, 1981.
Dougherty, T.J., "Photosensitizers: Therapy and Detection of Malignant Tumors," Photochemistry and Photobiology, 45:879-889, 1987.
Ehrenberg, et al., "The Binding and Photosensitization Effects of Tetrabenzoporphyrins and Texaphyrin in Bacterial Cells," Lasers in Medical Science, 8:197-203, 1993.
Favilla, et al., "Photodynamic therapy: a 5-year study of its effectiveness in the treatment of posterior uveal melanoma, and evaluation of haematoporphyrin uptake and photocytotoxicity of melanoma cells in tissue culture," Melanoma Research, 5(5):355-364, Oct., 1995. (abstract only).
Haylett, et al., "Pharmacokinetic and therapeutic outcome in melanoma cells of the administration of symmetric and asymmetric cationic photosensitizers," Cancer Letters, 88:191-199, 1995.
Horstman, Judith, "Study to examine skin cancer drug activated by light," Stanford University Campus Report, Mar. 1996.
Hungerford, J.L., "Management of Ocular Melanoma," British Medical Bulletin, 51:694-716, 1995.
Jimbow, et al., "Melanin Pigments and Melanosomal Proteins as Differentiation Markers Unique to Normal and Neoplastic Malenocytes," The Journal of Investigative Dermatology, 259S-268S, 1993.
Kimura, et al., Macrocyclic Polyamines as Biological Cation and Anion Complexones--An Application to Calculi Dissolution, Topics in Current Chemistry, 128, Biomimetic and Bioorganic Chemistry, VII+265P, Springer, Verlag, Berlin, West Germany, pp. 113-141, 1985.
Konig, et al., "PDT of Tumor-bearing Mice Using Liposome Delivered Texaphyrins," Photodynamic Therapy & Biomedical Laser Applications, Spinelli, et al., Elsevier Science Publishers, 1992.
Konig, et al. "Photodynamic Activity of Liposome-Delivered Cd-Texaphyrin Using Tumor-Bearing Nude Mice," Lasers in Surgery and Medicine, 13:522-527, 1993.
Leff, D.N., "Texas `Son-of-Porphyrin` Molecule Lassos Europium to Kill Drug Resistance Gene," BioWorld Today, 5:1-3, 1994.
Leunig, et al., "Tumour localisation kinetics of photofrin and three synthetic porphyrinoids in an amelanotic melanoma of the hamster," Br. J. Cancer, 68:225-234, 1993.
Lingam, et al., "Intraoperative Identification of sentinel lymph node in patients with malignant melanoma," British Journal of Cancer, 75(10), 1505-1508, May, 1997.
McCartney, A.C.E., "Pathology of ocular melanomas," British Medical Bulletin, 51:678-693, 1995.
Mellado, et al., "Detection of Circulating Neoplastic Cells by Reverse-Transcriptase Polymerase Chain Reaction in Malignant Melanoma: Association with Clinical Stage and Prognosis," Journal of Clinical Oncology, 14:2091-2097, 1996.
Menon, et al., "Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds," Cancer Letters, 95:221-225, 1995.
Morgan, et al., "Second Generation Sensitizers: Where Are We and Where Should We Be Going?" Future Directions and Applications in Photodynamic Therapy, pp. 87-106, SPIE Institute Series vol. IS 6, 1990.
Nannmark, et al., Microvessel Origin and Distribution in Pulmonary Metastases of B16 Melanoma: Implication for Adoptive Immunotherapy, Cancer Research, 55:4627-4632, 1995.
Nelson, et al., "Photodynamic Therapy of Human Malignant Melanoma Xenografts in Athymic Nude Mice," Journal of the National Cancer Institute, 80:56-60, 1988.
Pharmacyclics Press Release, "Pharmacyclics Completes Phase I Lu-Tex Trials in Photodynamic Cancer Treatment," Sunnyvale, California, Jan. 7, 1997.
Pharmacyclics Press Release, "Pharmacyclics Expands Photodynamic Therapy Trial to Stanford," Sunnyvale, California, Mar. 28, 1996.
Pharmacyclics Press Release, "Pharmacyclics Present Results and Updates Status for Photodynamic Therapy Agent at ASCO Meeting," Sunnyvale, California, May 19, 1997.
Pharmacyclics Press Release, "Pharmacyclics, Hoechst Celanese Forge Manufacturing Pact for Photodynamic Therapy and Radiation Sensitizer Products," Sunnyvale, California, Sep. 12, 1996.
Pharmacyclics Press Release, "Pharmacyclics' Photodynamic Therapy Agent Lu-Tex is Well Tolerated and Demonstrates Activity in a Multicenter Phase I Cancer Trial," Sunnyvale, California, Jun. 17, 1996.
Sealy, et al., "Photosensitization of Melanin: An Electron Spin Reasonance Study of Sensitized Radical Production and Oxygen Consumption," Photochemistry and Photobiology, 40:453-459, 1984.
Sessler, et al., "Anion binding: a new direction in porphyrin-related research," Pure & Appl. Chem., 65(3):393-398, 1993.
Sessler, et al., "Expanded Porphyrins, Receptors for Cationic, Anionic, and Neutral Substrates," Transition Metals in Supremolecular Chemistry, L. Fabbrizzi and A. Poggi, Editors, NATO ASI Series, Kluwer, Amsterdam, pp. 391-408, 1994.
Sessler, et al., "Gadolinium (III) Texaphyrin: A Novel MRI Contrast Agent," J. Am. Chem. Soc., 115:10368-10369, 1993.
Sessler, et al., "Preparation of Lanthanide (III) Texaphyrin Complexes and Their Applications to Magnetic Resonance Imaging and Photodynamic Therapy," INOR (300) Abstracts of Papers Part 1, 204.sup.th ACS National Meeting 0-8412-2467-6, American Chemical Society, Washington, D.C., Aug. 23-28, 1992.
Sessler, et al., "Synthesis and Applications of Schiff-Base Derived `Expanded Porphyrins`", INOR (100) Abstracts of Papers Part 1, 204.sup.th ACS National Meeting 0-8412-2467-6, American Chemical Society, Washington, D.C., Aug. 23-28, 1992.
Sessler, et al., "Synthesis and Binding Properties of Monomeric and Dimeric Guanine and Cytosine Amine Derivatives," J. Org. Chem., 57:818-826, 1992.
Sessler, et al., "Synthesis a
Woodburn Kathryn W.
Young Stuart W.
Huff Sheela
Pharmacyclics Inc.
LandOfFree
Use of texaphyrins in detection of melanin and melanin metabolit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of texaphyrins in detection of melanin and melanin metabolit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of texaphyrins in detection of melanin and melanin metabolit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1678531